Inhibikase Therapeutics files initial beneficial ownership statement for director Scott M. Wasserman
IKT•Director Scott M. Wasserman filed an initial beneficial ownership statement dated October 21, 2026.
1. Ownership filing
Inhibikase Therapeutics director Scott M. Wasserman filed an initial statement of beneficial ownership dated October 21, 2026.
